VREX Varex Imaging Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: VREX

Price (delayed)

$15.59

Market cap

$623.6M

P/E Ratio

14.99

Dividend/share

N/A

EPS

$1.04

Enterprise value

$952.4M

Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of ...

Highlights
The company's quick ratio rose by 32% YoY and by 18% QoQ
The P/E is 28% below the last 4 quarters average of 20.8
The company's net income rose by 47% YoY but it fell by 6% QoQ
The EPS is up by 44% year-on-year but it has declined by 6% since the previous quarter
The revenue has contracted by 2.7% YoY and by 2.5% from the previous quarter
VREX's gross profit is down by 2.4% QoQ and by 2.4% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.vareximaging.com
Peers: NNOX

Key stats

What are the main financial stats of VREX
Market
Shares outstanding
40M
Market cap
$623.6M
Enterprise value
$952.4M
Valuations
Price to earnings (P/E)
14.99
Price to book (P/B)
1.08
Price to sales (P/S)
0.74
EV/EBIT
15.9
EV/EBITDA
10.08
EV/Sales
1.11
Earnings
Revenue
$855.8M
EBIT
$59.9M
EBITDA
$94.5M
Free cash flow
$72.4M
Per share
EPS
$1.04
Free cash flow per share
$1.78
Book value per share
$14.4
Revenue per share
$21.03
TBVPS
$23.2
Balance sheet
Total assets
$1.25B
Total liabilities
$661.5M
Debt
$470.6M
Equity
$576.1M
Working capital
$497.8M
Liquidity
Debt to equity
0.82
Current ratio
4.23
Quick ratio
2.21
Net debt/EBITDA
3.48
Margins
EBITDA margin
11%
Gross margin
32.4%
Net margin
4.9%
Operating margin
7.1%
Efficiency
Return on assets
3.4%
Return on equity
7.5%
Return on invested capital
5.4%
Return on capital employed
5.5%
Return on sales
7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VREX stock price

How has the Varex Imaging stock price performed over time
Intraday
-5.11%
1 week
-7.15%
1 month
-13.44%
1 year
-24.43%
YTD
-23.95%
QTD
-13.87%

Financial performance

How have Varex Imaging's revenue and profit performed over time
Revenue
$855.8M
Gross profit
$277.2M
Operating income
$60.4M
Net income
$41.9M
Gross margin
32.4%
Net margin
4.9%
Varex Imaging's net margin has surged by 53% YoY but it has decreased by 3.9% QoQ
The company's net income rose by 47% YoY but it fell by 6% QoQ
The operating income is down by 21% year-on-year and by 12% since the previous quarter
The operating margin has declined by 18% year-on-year and by 9% since the previous quarter

Growth

What is Varex Imaging's growth rate over time

Valuation

What is Varex Imaging stock price valuation
VREX P/E details
P/E
14.99
P/B
1.08
P/S
0.74
EV/EBIT
15.9
EV/EBITDA
10.08
EV/Sales
1.11
The EPS is up by 44% year-on-year but it has declined by 6% since the previous quarter
The P/E is 28% below the last 4 quarters average of 20.8
The P/B is 40% lower than the 5-year quarterly average of 1.8 and 28% lower than the last 4 quarters average of 1.5
Varex Imaging's equity has increased by 11% YoY
The P/S is 33% less than the 5-year quarterly average of 1.1 and 18% less than the last 4 quarters average of 0.9
The revenue has contracted by 2.7% YoY and by 2.5% from the previous quarter

Efficiency

How efficient is Varex Imaging business performance
The ROA rose by 42% YoY but it fell by 6% QoQ
VREX's return on equity is up by 36% year-on-year but it is down by 9% since the previous quarter
The ROIC has contracted by 25% YoY and by 13% from the previous quarter
The return on sales has declined by 19% year-on-year and by 9% since the previous quarter

Dividends

What is VREX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VREX.

Financial health

How did Varex Imaging financials performed over time
The total assets is 89% more than the total liabilities
The company's quick ratio rose by 32% YoY and by 18% QoQ
The current ratio has increased by 8% year-on-year
Varex Imaging's debt is 18% lower than its equity
Varex Imaging's equity has increased by 11% YoY
Varex Imaging's debt to equity has decreased by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.